Leukemia Clinical Trials

A listing of Leukemia medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

 

Alabama

UPDATED

Birmingham Alabama 35294

A clinical research study of Standard dose cytarabine for induction, SGN-CD33A, Daunorubicin and High dose cytarabine for consolidation for the treatment of Acute Myeloid Leukemia or Acute Myelogenous Leukemia (AML)

UPDATED

Birmingham Alabama 35294

Patients are needed to participate in a clinical research study of SGN-CD33A to evaluate Acute Myelogenous Leukemia or Acute Myeloid Leukemia

UPDATED

Huntsville Alabama 35805

Patients are needed to participate in a clinical research study of Ublituximab and ibrutinib to evaluate Chronic Lymphocytic Leukemia (CLL)

UPDATED

Muscle Shoals Alabama 35661

A clinical research study for the treatment of Chronic Myeloid Leukemia

Birmingham Alabama 35294

A clinical trial to evaluate treatments for patients with Acute Myeloid Leukemia

View More ▼

Birmingham Alabama 35294

A clinical trial to evaluate treatments using AMG 232 for patients with Acute Myeloid Leukemia

Birmingham Alabama 35294

A Phase 1 clinical study for patients with Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia

Birmingham Alabama 35233

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Birmingham Alabama 35249-6909

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Birmingham Alabama 35249

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Birmingham Alabama 35294

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Birmingham Alabama 35294

Patients are needed to participate in a clinical research study evaluating ASP2215 for the treatment of Acute Myeloid Leukemia

Birmingham Alabama 35249

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Birmingham Alabama 35294

Patients are needed to participate in a clinical research study of SGN-CD19A to evaluate Burkitt Lymphoma or Precursor B-cell Lymphoblastic Leukemia-Lymphoma

Birmingham Alabama 35233

Patients are needed to participate in a clinical research study of SGN-CD19A to evaluate Burkitt Lymphoma or Precursor B-cell Lymphoblastic Leukemia-Lymphoma

Huntsville Alabama 35805

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Mobile Alabama 36604

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Muscle Shoals Alabama 35661

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Alaska

Anchorage Alaska 99503

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Arizona

UPDATED

Oro Valley Arizona 85755

Patients are needed to participate in a clinical research study of Ublituximab and ibrutinib to evaluate Chronic Lymphocytic Leukemia (CLL)

UPDATED

Scottsdale Arizona 85259-5499

Patients are needed to participate in a clinical research study of SGI-110 (guadecitabine) and Treatment Choice to evaluate Acute Myeloid Leukemia (AML)

UPDATED

Sedona Arizona 86336

A clinical research study for the treatment of Chronic Myeloid Leukemia

UPDATED

Tucson Arizona 85704

A clinical research study for the treatment of Chronic Myeloid Leukemia

UPDATED

Tucson Arizona 85724

A Phase 3 clinical study for patients with AML

View More ▼

UPDATED

Tucson Arizona 85710

Patients are needed to participate in a clinical research study of Ublituximab and ibrutinib to evaluate Chronic Lymphocytic Leukemia (CLL)

UPDATED

Tucson Arizona 85704

Patients are needed to participate in a clinical research study of Ublituximab and ibrutinib to evaluate Chronic Lymphocytic Leukemia (CLL)

Phoenix Arizona

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Phoenix Arizona 85016

Patients are needed to participate in a clinical research study of Idelalisib and Rituximab to evaluate B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study evaluating ASP2215 for the treatment of Acute Myeloid Leukemia

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study of EPZ-5676

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study of SGN-CD19A to evaluate Burkitt Lymphoma or Precursor B-cell Lymphoblastic Leukemia-Lymphoma

Tucson Arizona 85710

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Tucson Arizona 85710

Patients are needed to participate in a clinical research study of Idelalisib and Rituximab to evaluate B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion

Arkansas

UPDATED

Fayetteville Arkansas 72703

Patients are needed to participate in a clinical research study of Ublituximab and ibrutinib to evaluate Chronic Lymphocytic Leukemia (CLL)

UPDATED

Hot Springs Arkansas 71913

A clinical research study for the treatment of Chronic Myeloid Leukemia

UPDATED

Jonesboro Arkansas 72401

A clinical research study for the treatment of Chronic Myeloid Leukemia

UPDATED

Little Rock Arkansas 72205

A clinical research study for the treatment of Chronic Myeloid Leukemia

Hot Springs Arkansas 71913

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

California

UPDATED

Anaheim California 92801

A clinical research study for the treatment of Chronic Myeloid Leukemia

UPDATED

Anaheim California 92801

A Phase 3 clinical study for patients with Chronic Lymphocytic Leukemia, High Risk

UPDATED

Duarte California 91010-3000

A clinical research study of Standard dose cytarabine for induction, SGN-CD33A, Daunorubicin and High dose cytarabine for consolidation for the treatment of Acute Myeloid Leukemia or Acute Myelogenous Leukemia (AML)

UPDATED

Duarte California 91010

A Phase 3 clinical study for patients with AML

UPDATED

Duarte California 91010-3000

Patients are needed to participate in a clinical research study of SGN-CD33A to evaluate Acute Myelogenous Leukemia or Acute Myeloid Leukemia

View More ▼

UPDATED

Escondido California 92025

A clinical research study for the treatment of Chronic Myeloid Leukemia

UPDATED

Glendora California 91741

A clinical research study for the treatment of Chronic Myeloid Leukemia

UPDATED

La Jolla California 92093

Patients are needed to participate in a clinical research study of CLT-008 and G-CSF to evaluate Acute Myeloid Leukemia

UPDATED

Los Angeles California 90033

A clinical research study for the treatment of Chronic Myeloid Leukemia

UPDATED

Los Angeles California 90095

A Phase 3 clinical study for patients with AML

UPDATED

Los Angeles California 90033

Patients are needed to participate in a clinical research study of SGI-110 (guadecitabine) and Treatment Choice to evaluate Acute Myeloid Leukemia (AML)